China's Sinovac COVID-19 shooting proved highly effective in Chile
The CoronaVac vaccine, developed by เกมสล็อต Chinese drugmaker Sinovac, was once again proven to be highly effective in another large-scale Phase 3 trial in Chile. According to a new study published Wednesday in the New England Journal of Medicine.
Results of nationwide vaccination campaigns across the country From February 2 to May 1, the inactivated vaccine was effective: 65.9 percent against COVID-19 showed symptoms, 87.5 percent prevented hospitalization, 90.3 percent were in ICU, and 86.3 percent had died at COVID-19. concerned
The research involved 10.2 million participants aged 16 and over. The findings suggest similar protections were in place for people over 60 as did the other groups.The vaccine can be stored and transported at 2-8°C. It has been approved for emergency use in more than 20 countries and is in phase 3 trials from mid-2020 in Brazil, Indonesia, Chile and Turkey.
Efficacy in hospitalization was reported by more than 90 percent in both Brazilian and Indonesian studies. and the latest experimental results in Turkey. published in the leading medical journal The Lancet on Thursday. It has been shown to be 83.5% effective against symptomatic COVID-19.It was also approved for emergency use by the World Health Organization on June 1, meaning it meets international safety, efficiency and manufacturing standards.